MAK-4 and -5 Supplemented Diet Inhibits Liver Carcinogenesis in Mice

Overview

Journal BMC Complement Altern Med

Publisher Biomed Central

Specialty Rehabilitation Medicine

Date 2007 Jun 15

PMID 17559639

Citations 3

Authors

Marialetizia Penza

Claudia Montani

Marija Jeremic

Giovanna Mazzoleni

W L Wendy Hsiao

Maurizio Marra

Hari Sharma

Diego Di Lorenzo

Affiliations

Soon will be listed here.

Abstract

Background: Maharishi Amrit Kalash (MAK) is an herbal formulation composed of two herbal mixtures, MAK-4 and MAK-5. These preparations are part of a natural health care system from India, known as Maharishi Ayur-Veda. MAK-4 and MAK-5 are each composed of different herbs and are said to have maximum benefit when used in combination. This investigation evaluated the cancer inhibiting effects of MAK-4 and MAK-5, in vitro and in vivo.

Methods: In vitro assays: Aqueous extracts of MAK-4 and MAK-5 were tested for effects on ras induced cell transformation in the Rat 6 cell line assessed by focus formation assay. In vivo assays: Urethane-treated mice were put on a standard pellet diet or a diet supplemented with MAK-4, MAK-5 or both. At 36 weeks, livers were examined for tumors, sera for oxygen radical absorbance capacity (ORAC), and liver homogenates for enzyme activities of glutathione peroxidase (GPX), glutathione-S-transferase (GST), and NAD(P)H: quinone reductase (QR). Liver fragments of MAK-fed mice were analyzed for connexin (cx) protein expression.

Results: MAK-5 and a combination of MAK-5 plus MAK-4, inhibited ras-induced cell transformation. In MAK-4, MAK-5 and MAK4+5-treated mice we observed a 35%, 27% and 46% reduction in the development of urethane-induced liver nodules respectively. MAK-4 and MAK4+5-treated mice had a significantly higher ORAC value (P < 0.05) compared to controls (200.2 +/- 33.7 and 191.6 +/- 32.2 vs. 152.2 +/- 15.7 ORAC units, respectively). The urethane-treated MAK-4, MAK-5 and MAK4+5-fed mice had significantly higher activities of liver cytosolic enzymes compared to the urethane-treated controls and to untreated mice: GPX(0.23 +/- 0.08, 0.21 +/- 0.05, 0.25 +/- 0.04, 0.20 +/- 0.05, 0.21 +/- 0.03 U/mg protein, respectively), GST (2.0 +/- 0.4, 2.0 +/- 0.6, 2.1 +/- 0.3, 1.7 +/- 0.2, 1.7 +/- 0.2 U/mg protein, respectively) and QR (0.13 +/- 0.02, 0.12 +/- 0.06, 0.15 +/- 0.03, 0.1 +/- 0.04, 0.11 +/- 0.03 U/mg protein, respectively). Livers of MAK-treated mice showed a time-dependent increased expression of cx32.

Conclusion: Our results show that a MAK-supplemented diet inhibits liver carcinogenesis in urethane-treated mice. The prevention of excessive oxidative damage and the up-regulation of connexin expression are two of the possible effects of these products.

Citing Articles

Efficacy and safety of the Ayurvedic herbal preparation Maharishi Amrit Kalash: a systematic review of randomized controlled trials.

Koch A, Patel M, Gupta S, Wullenkord R, Jeitler M, Kessler C Front Med (Lausanne). 2024; 11:1325037.

PMID: 38690176 PMC: 11058942. DOI: 10.3389/fmed.2024.1325037.

Morphological and Chemoprofile (Liquid Chromatography-mass Spectroscopy and Gas Chromatography-mass Spectroscopy) Comparisons of Cyperus scariosus R. Br and Cyperus rotundus L.

Kakarla L, Katragadda S, Botlagunta M Pharmacogn Mag. 2016; 11(Suppl 3):S439-47.

PMID: 26929579 PMC: 4745215. DOI: 10.4103/0973-1296.168975.

A survey on herbal management of hepatocellular carcinoma.

Abdel-Hamid N, Nazmy M, Mahmoud A, Fawzy M, Youssof M World J Hepatol. 2011; 3(7):175-83.

PMID: 21866249 PMC: 3158906. DOI: 10.4254/wjh.v3.i7.175.

References

Inaba R, Sugiura H, Iwata H . Immunomodulatory effects of Maharishi Amrit Kalash 4 and 5 in mice. Nihon Eiseigaku Zasshi. 1995; 50(4):901-5. DOI: 10.1265/jjh.50.901. View

Kojima T, Mitaka T, Mizuguchi T, Mochizuki Y . Effects of oxygen radical scavengers on connexins 32 and 26 expression in primary cultures of adult rat hepatocytes. Carcinogenesis. 1996; 17(3):537-44. DOI: 10.1093/carcin/17.3.537. View

Heber D, Lu Q . Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood). 2002; 227(10):920-3. DOI: 10.1177/153537020222701013. View

Drinkwater N, Ginsler J . Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis. 1986; 7(10):1701-7. DOI: 10.1093/carcin/7.10.1701. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Sun Y . Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med. 1990; 8(6):583-99. DOI: 10.1016/0891-5849(90)90156-d. View

Freeman A, Price P, IGEL H, Young J, Maryak J, HUEBNER R . Morphological transformation of rat embryo cells induced by diethylnitrosamine and murine leukemia viruses. J Natl Cancer Inst. 1970; 44(1):65-78. View

Nelson C, Baetcke K, Frith C, Kodell R, Schieferstein G . The influence of sex, dose, time, and cross on neoplasia in mice given benzidine dihydrochloride. Toxicol Appl Pharmacol. 1982; 64(2):171-86. DOI: 10.1016/0041-008x(82)90214-9. View

Yamasaki H, Naus C . Role of connexin genes in growth control. Carcinogenesis. 1996; 17(6):1199-213. DOI: 10.1093/carcin/17.6.1199. View

10.

Banoub R, Fernstrom M, Ruch R . Lack of growth inhibition or enhancement of gap junctional intercellular communication and connexin43 expression by beta-carotene in murine lung epithelial cells in vitro. Cancer Lett. 1996; 108(1):35-40. DOI: 10.1016/s0304-3835(96)04367-4. View

11.

Rodella L, Borsani E, Rezzani R, Lanzi R, Lonati C, Bianchi R . MAK-5 treatment enhances the nerve growth factor-mediated neurite outgrowth in PC12 cells. J Ethnopharmacol. 2004; 93(2-3):161-6. DOI: 10.1016/j.jep.2003.12.033. View

12.

Tsuda H, Asamoto M, Ochiya T, Naito A, Ota T, Sekiya T . High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis. Mutat Res. 2001; 477(1-2):173-82. DOI: 10.1016/s0027-5107(01)00118-x. View

13.

Paul D . Molecular cloning of cDNA for rat liver gap junction protein. J Cell Biol. 1986; 103(1):123-34. PMC: 2113807. DOI: 10.1083/jcb.103.1.123. View

14.

Vinken M, Vanhaecke T, Papeleu P, Snykers S, Henkens T, Rogiers V . Connexins and their channels in cell growth and cell death. Cell Signal. 2005; 18(5):592-600. DOI: 10.1016/j.cellsig.2005.08.012. View

15.

Yamasaki H, Krutovskikh V, Mesnil M, Tanaka T, Omori Y . Role of connexin (gap junction) genes in cell growth control and carcinogenesis. C R Acad Sci III. 1999; 322(2-3):151-9. DOI: 10.1016/s0764-4469(99)80038-9. View

16.

Cao G, Alessio H, Cutler R . Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med. 1993; 14(3):303-11. DOI: 10.1016/0891-5849(93)90027-r. View

17.

Gonzalez C . Nutrition and cancer: the current epidemiological evidence. Br J Nutr. 2006; 96 Suppl 1:S42-5. DOI: 10.1079/bjn20061699. View

18.

Hsiao W, Pai H, Matsui M, Weinstein I . Effects of specific fatty acids on cell transformation induced by an activated c-H-ras oncogene. Oncogene. 1990; 5(3):417-21. View

19.

Prasad K, Edwards-Prasad J, Kentroti S, Brodie C, Vernadakis A . Ayurvedic (science of life) agents induce differentiation in murine neuroblastoma cells in culture. Neuropharmacology. 1992; 31(6):599-607. DOI: 10.1016/0028-3908(92)90193-s. View

20.

Wigler M, Pellicer A, Silverstein S, Axel R . Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell. 1978; 14(3):725-31. DOI: 10.1016/0092-8674(78)90254-4. View